Obicetrapib
Showing 1 - 12 of 12
Hyperlipidemias, Dyslipidemias Trial (Obicetrapib)
Not yet recruiting
- Hyperlipidemias
- Dyslipidemias
- Obicetrapib
- (no location specified)
Aug 2, 2023
Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)
Not yet recruiting
- Healthy Volunteer Study
- Fixed-Dose Combination (FDC) Tablet
- (no location specified)
Sep 22, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Healthy Volunteers Trial in Toronto (Obicetrapib, Atorvastatin Calcium, Rosuvastatin Calcium)
Not yet recruiting
- Healthy Volunteers
- Obicetrapib
- +2 more
-
Toronto, Ontario, CanadaMark M Feldman
Oct 10, 2023
Hepatic Impairment, Healthy Trial in Saint Paul, San Antonio (Obicetrapib)
Not yet recruiting
- Hepatic Impairment
- Healthy
- Obicetrapib
-
Saint Paul, Minnesota
- +1 more
Sep 21, 2023
Dyslipidemia, Hypercholesterolemia, High Cholesterol Trial in Japan (Obicetrapib)
Recruiting
- Dyslipidemia
- +2 more
- Obicetrapib
-
Fukuyama, Japan
- +9 more
Aug 10, 2022
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Ezetimibe 10mg, Obicetrapib )
Active, not recruiting
- Dyslipidemias
- +2 more
- Obicetrapib
- +3 more
-
Gardena, California
- +6 more
Jul 14, 2022
Early Alzheimer's Disease Trial in Amsterdam (Obicetrapib)
Recruiting
- Early Alzheimer's Disease
- Obicetrapib
-
Amsterdam, NetherlandsBrain Research Center Amsterdam
Feb 9, 2022
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Placebo)
Recruiting
- Dyslipidemias
- +8 more
- Obicetrapib
- Placebo
-
Sarasota, Florida
- +11 more
Aug 10, 2022
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in Netherlands, United States (Obicetrapib 5mg, Ezetimibe 10mg,
Completed
- Dyslipidemias
- +2 more
- Obicetrapib 5mg
- +2 more
-
Lincoln, California
- +8 more
Jul 8, 2021
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib)
Completed
- Dyslipidemias
- +2 more
- Obicetrapib
-
Anniston, Alabama
- +18 more
Sep 3, 2021
Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Placebo, Obicetrapib)
Recruiting
- Dyslipidemias
- +4 more
- Placebo
- Obicetrapib
-
Anniston, Alabama
- +126 more
Dec 8, 2022